Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance (Q45370440)

13 December 2017

title

Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance (English)

1 reference

13 December 2017

0 references

1 reference

Drenna Waldrop-Valverde

3

object named as

Drenna Waldrop-Valverde

0 references

author name string

Adarsh M Kumar

1

1 reference

13 December 2017

Raymond L Ownby

2

1 reference

13 December 2017

Benny Fernandez

4

1 reference

13 December 2017

Mahendra Kumar

5

1 reference

13 December 2017

publication date

14 December 2010

1 reference

13 December 2017

published in

Journal of NeuroVirology

1 reference

13 December 2017

volume

17

1 reference

13 December 2017

issue

1

1 reference

13 December 2017

page(s)

26-40

1 reference

Dementia and neurocognitive disorders due to HIV-1 infection

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Caudate blood flow and volume are reduced in HIV+ neurocognitively impaired patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Motor dysfunction in HIV-infected patients without clinically detectable central-nervous deficit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Updated research nosology for HIV-associated neurocognitive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Binding, internalization, and membrane incorporation of human immunodeficiency virus-1 at the blood-brain barrier is differentially regulated

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

HIV dementia: the role of the basal ganglia and dopaminergic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus Monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

HIV and the 7-transmembrane domain receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Assessment of AIDS-related cognitive changes: recommendations of the NIMH Workshop on Neuropsychological Assessment Approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Frontal-subcortical circuits and human behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Variable patterns of neuropsychological performance in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

The neural basis of the central executive system of working memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Decreased homovanilic acid in cerebrospinal fluid correlates with impaired neuropsychologic function in HIV-1-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Antiretroviral drugs and the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

HIV-1 proviral DNA load across neuroanatomic regions of individuals with evidence for HIV-1-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Dopamine interaction with other neurotransmitter systems: Relevance in the pathophysiology and treatment of CNS disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

The role of the basal ganglia in learning and memory: neuropsychological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Paced auditory serial-addition task: a measure of recovery from concussion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Extrapyramidal symptoms in AIDS patients given low-dose metoclopramide or chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Biochemical aspects of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Extrapyramidal symptoms due to dopamine-blocking agents in patients with AIDS encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Mechanisms of neuronal injury and death in HIV-1 associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Human immunodeficiency virus type 1 RNA Levels in different regions of human brain: quantification using real-time reverse transcriptase-polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Cerebrospinal fluid catecholamine metabolites in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Opposing roles for dopamine and serotonin in the modulation of human spatial working memory functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

HIV, the brain, children, HAART and 'neuro-HAART': a complex mix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Spectrum of human immunodeficiency virus-associated neocortical damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

HIV dementia: an evolving disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

HIV in the brain: RNA levels and patterns of zidovudine resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Parkinsonism with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

The National NeuroAIDS Tissue Consortium: a new paradigm in brain banking with an emphasis on infectious disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

The AIDS dementia complex: I. Clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Dopamine and the regulation of cognition and attention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Substantia nigra hyperechogenicity and CSF dopamine depletion in HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Planning and Spatial Working Memory: a Positron Emission Tomography Study in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Verbal memory performance of patients with human immunodeficiency virus infection: evidence of subcortical dysfunction. The HNRC Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

White matter abnormalities in HIV-1 infection: a diffusion tensor imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Dopamine and the origins of human intelligence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Globus pallidus dopamine and Parkinson motor subtypes: clinical and brain biochemical correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

A meta-analysis of the neuropsychological sequelae of HIV infection

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

21 January 2018

12 December 2020

Early penetration of the blood-brain-barrier by HIV.

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

The prevalence and incidence of neurocognitive impairment in the HAART era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex: A proton magnetic resonance spectroscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Increased cerebral blood volume in HIV-positive patients detected by functional MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Dopamine metabolism in the cerebrospinal fluid of drug-free schizophrenic patients with and without cortical atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Dopamine and homovanillic acid concentrations in striatal and limbic regions of human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Decreased brain dopaminergic transporters in HIV-associated dementia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Cognitive neuropsychology of HIV-associated neurocognitive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-010-0003-4

Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry

21 January 2018

1 reference

12 December 2020

Distribution of brain HIV load in AIDS.

1 reference

12 December 2020

Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center.

1 reference

12 December 2020

Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia

1 reference

12 December 2020

Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA).

1 reference

12 December 2020

Nigral degeneration in acquired immune deficiency syndrome (AIDS)

1 reference

12 December 2020

The effects of human immunodeficiency virus in the central nervous system

1 reference

12 December 2020

Cerebrospinal fluid dopamine in HIV-1 infection

1 reference

12 December 2020

Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force

1 reference

12 December 2020

Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging

1 reference

12 December 2020

Neuronal damage of the substantia nigra in HIV-1 infected brains

1 reference

12 December 2020

HIV infection and dementia

1 reference

12 December 2020

HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes.

1 reference

12 December 2020

HIV-associated cognitive impairment before and after the advent of combination therapy

1 reference

12 December 2020

The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center.

1 reference

12 December 2020

Cognitive Effects of HIV-1 Infection.

1 reference

12 December 2020

Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain

1 reference

12 December 2020

Dopamine deficits in the brain: the neurochemical basis of parkinsonian symptoms in AIDS.

1 reference

12 December 2020

Neuropsychological abnormalities among HIV-infected individuals in a community-based sample.

1 reference

12 December 2020

Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy

1 reference

12 December 2020

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

1 reference

12 December 2020

10.1007/S13365-010-0003-4

Identifiers

DOI

1 reference

Dimensions Publication ID

13 December 2017

1039252653

0 references

1 reference